ClinicalTrials.Veeva

Menu

Obalon in Children With Severe Obesity

B

Bambino Gesù Hospital and Research Institute

Status and phase

Completed
Phase 3

Conditions

Severe Pediatric Obesity (BMI > 97° pc -According to Centers for Disease Control and Prevention BMI Charts-)
Glycemic Intolerance
Altered Liver Function Tests

Treatments

Device: Swallowable Obalon® Gastric Balloon

Study type

Interventional

Funder types

Other

Identifiers

NCT02137330
539/RA
539/RA Obalon (Registry Identifier)

Details and patient eligibility

About

The ongoing global rise in the prevalence of overweight and obesity among all ages and among all ethnic groups, figures into a real epidemic phenomenon. This is accompanied by a higher incidence in serious health risks, already present at an early age, "switching-on" the engine towards obesity-related co-morbid diseases and morbid obesity. Weight loss is the only way to avoid systemic and cardiovascular complications of obesity.

Weight loss devices have been recently introduced in bariatric surgery, also in children. They mostly require invasive procedures to be applied. Mini-invasive devices would be needed to obtain weight loss in the pediatric population, since the early age of involved patients.

Obalon intragastric balloons, are swallowable devices. They are filled with liquid or air, and have been used to induce weight loss in obese adults. The investigators aimed to perform a pilot study in pediatrics, and monitor weight loss, metabolic and cardiovascular parameters modifications, after up-to-3 Obalon® Gastric Balloons placement.

Enrollment

10 patients

Sex

All

Ages

9 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Weight > 97° pc -CDC BMI charts-

Exclusion criteria

  • Prevous abdominal surgery
  • Functional gastrointestinal motility disorders

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

10 participants in 2 patient groups

Obalon Arm
Experimental group
Description:
Children swalowed up to 3 intragastric balloons
Treatment:
Device: Swallowable Obalon® Gastric Balloon
Dietary and lifestyle changes Arm
No Intervention group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems